Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith
Emergent BioSolutions Inc. (NYSE: EBS) has launched a new opioid emergency awareness campaign called 'Lay, Spray, Stay' featuring Pro Football Hall of Famer Emmitt Smith. The campaign, part of Emergent's Ready to Rescue initiative, aims to educate the public on responding to opioid emergencies using NARCAN® Nasal Spray. Created in partnership with SAFE Project, the campaign includes video and radio segments to raise awareness about the three-step method for potentially saving lives during suspected opioid poisonings.
The initiative addresses the alarming rate of opioid-related deaths in the U.S., with over 100,000 drug overdose fatalities in 2023. NARCAN® Nasal Spray, containing naloxone, is available over the counter and designed to rapidly reverse opioid poisoning effects. The campaign emphasizes the importance of preparedness and aims to break down stigma associated with accidental opioid poisonings.
Emergent BioSolutions Inc. (NYSE: EBS) ha lanciato una nuova campagna di sensibilizzazione per le emergenze legate agli oppiacei chiamata 'Lay, Spray, Stay', con il famoso ex giocatore di football Emmitt Smith. La campagna, parte dell'iniziativa Ready to Rescue di Emergent, mira a educare il pubblico su come rispondere alle emergenze legate agli oppiacei utilizzando il NARCAN® Nasal Spray. Creata in collaborazione con SAFE Project, la campagna include segmenti video e radio per aumentare la consapevolezza riguardo al metodo in tre fasi per salvare potenzialmente delle vite durante sospette intossicazioni da oppiacei.
L'iniziativa affronta l'allarmante tasso di morti legate agli oppiacei negli Stati Uniti, con oltre 100.000 decessi per overdose nel 2023. Il NARCAN® Nasal Spray, contenente naloxone, è disponibile senza prescrizione medica e progettato per invertire rapidamente gli effetti di un'intossicazione da oppiacei. La campagna sottolinea l'importanza della preparazione e mira a ridurre lo stigma associato alle intossicazioni accidentali da oppiacei.
Emergent BioSolutions Inc. (NYSE: EBS) ha lanzado una nueva campaña de concientización sobre emergencias relacionadas con opioides llamada 'Lay, Spray, Stay', protagonizada por el miembro del Salón de la Fama del Fútbol Americano Emmitt Smith. La campaña, parte de la iniciativa Ready to Rescue de Emergent, tiene como objetivo educar al público sobre cómo responder a emergencias por opioides utilizando el NARCAN® Nasal Spray. Creada en colaboración con SAFE Project, la campaña incluye segmentos de video y radio para aumentar la conciencia sobre el método de tres pasos que puede salvar vidas durante sospechas de intoxicación por opioides.
La iniciativa aborda la alarmante tasa de muertes relacionadas con opioides en los EE. UU., con más de 100,000 muertes por sobredosis en 2023. El NARCAN® Nasal Spray, que contiene naloxona, está disponible sin receta y está diseñado para revertir rápidamente los efectos de la intoxicación por opioides. La campaña enfatiza la importancia de estar preparado y busca romper el estigma asociado con las intoxicaciones accidentales por opioides.
Emergent BioSolutions Inc. (NYSE: EBS)는 전 NFL 스타 Emmitt Smith가 출연하는 'Lay, Spray, Stay'라는 새로운 오피오이드 응급 인식 캠페인을 출시했습니다. 이 캠페인은 Emergent의 Ready to Rescue 이니셔티브의 일환으로, NARCAN® Nasal Spray를 사용하여 오피오이드 응급 상황에 대처하는 방법을 대중에게 교육하는 것을 목표로 하고 있습니다. SAFE Project와 협력하여 제작된 이 캠페인에는 의심되는 오피오이드 중독 상황에서 생명을 구할 수 있는 3단계 방법에 대한 인식을 높이기 위해 비디오 및 라디오 세그먼트가 포함되어 있습니다.
이 이니셔티브는 2023년 미국에서 100,000명 이상의 약물 과다복용 사망이라는 경고하는 오피오이드 관련 사망률을 다루고 있습니다. naloxone이 포함된 NARCAN® Nasal Spray는 일반의약품으로 판매되며, 오피오이드 중독의 영향들을 신속하게 역전시키도록 설계되었습니다. 이 캠페인은 준비의 중요성을 강조하고 우발적인 오피오이드 중독에 대한 낙인을 없애는 것을 목표로 하고 있습니다.
Emergent BioSolutions Inc. (NYSE: EBS) a lancé une nouvelle campagne de sensibilisation aux urgences liées aux opioïdes intitulée 'Lay, Spray, Stay' avec l'ancien joueur de football Emmitt Smith. Cette campagne, qui fait partie de l'initiative Ready to Rescue d'Emergent, vise à éduquer le public sur la manière de réagir aux urgences liées aux opioïdes en utilisant le NARCAN® Nasal Spray. Créée en partenariat avec SAFE Project, la campagne comprend des segments vidéo et radio pour sensibiliser au procédé en trois étapes pouvant potentiellement sauver des vies lors de soupçons d'empoisonnement par opioïdes.
Cette initiative répond au taux alarmant de décès liés aux opioïdes aux États-Unis, avec plus de 100 000 décès par overdose en 2023. Le NARCAN® Nasal Spray, contenant de la naloxone, est disponible en vente libre et est conçu pour inverser rapidement les effets des empoisonnements par opioïdes. La campagne souligne l'importance de la préparation et vise à réduire la stigmatisation associée aux empoisonnements accidentels par opioïdes.
Emergent BioSolutions Inc. (NYSE: EBS) hat eine neue Aufklärungskampagne zu Opioid-Notfällen mit dem Titel 'Lay, Spray, Stay' ins Leben gerufen, die von dem ehemaligen Football-Profi Emmitt Smith präsentiert wird. Die Kampagne, Teil der Initiative Ready to Rescue von Emergent, zielt darauf ab, die Öffentlichkeit über den Umgang mit Opioid-Notfällen unter Verwendung von NARCAN® Nasal Spray aufzuklären. In Zusammenarbeit mit SAFE Project erstellt, umfasst die Kampagne Video- und Radio-Beiträge, um das Bewusstsein für die dreistufige Methode zu schärfen, die potenziell Leben bei vermuteten Opioidvergiftungen retten kann.
Die Initiative thematisiert die alarmierende Rate von Opioid-bedingten Todesfällen in den USA, mit über 100.000 Todesfällen durch Drogenüberdosierung im Jahr 2023. Das NARCAN® Nasal Spray, das Naloxon enthält, ist rezeptfrei erhältlich und wurde entwickelt, um die Auswirkungen einer Opioidvergiftung schnell umzukehren. Die Kampagne betont die Bedeutung von Bereitschaft und zielt darauf ab, das Stigma im Zusammenhang mit versehentlichen Opioidvergiftungen abzubauen.
- Launch of 'Lay, Spray, Stay' public education campaign to raise awareness about opioid emergency response
- Partnership with SAFE Project and celebrity endorsement from Emmitt Smith to increase campaign reach
- Promotion of NARCAN® Nasal Spray, an over-the-counter opioid overdose reversal medication
- None.
- New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning
GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opioid emergency awareness public education campaign to prepare people across the country to help save a life with the ‘Lay, Spray, Stay’ method. Sponsored by Emergent and created in partnership with SAFE Project, a national nonprofit combating substance use, overdoses and addiction, the campaign stars Pro Football Hall of Famer, Emmitt Smith, in a series of public awareness video and radio segments. The effort supports Emergent’s national Ready to Rescue initiative, which breaks down the stigma associated with accidental opioid poisonings and informs Americans on the availability and use of NARCAN® Nasal Spray to help save a life.
Naloxone, the active ingredient in NARCAN® Nasal Spray, is a medication designed to rapidly reverses the effects of an opioid poisoning and is the standard of care for opioid overdose reversal. It is available over the counter and can be accessed at leading pharmacies and grocery stores nationwide, as well as online retailers.
“More than 100,000 people lost their lives to drug overdoses in 2023, and a majority were caused by opioids and synthetic opioids like fentanyl,” said Paul Williams, senior vice president and products business head at Emergent. “These individuals are loved ones, friends, community members, colleagues, neighbors, children. The tragic rate of fatal opioid emergencies is why we continue to educate the public on preparedness and increase widespread awareness around ‘Lay, Spray, Stay’ – three important steps that are critical when responding to an opioid emergency.”
“Through our Ready to Rescue initiative I’ve had the opportunity to meet so many people who want to step up and help in an opioid emergency; they just need the information and tools to do so,” said Emmitt Smith. “Most opioid-related deaths are preventable, and by raising awareness of the ‘Lay, Spray, Stay’ method, more people will be prepared to help save a life in an opioid emergency. Together, we can make a safer world for our children and future generations.”
Emergent partnered with SAFE Project – an organization founded by Sandy Winnefeld, the former Chairman of the Joint Chiefs of Staff, and his wife, Mary – when they lost their son to an accidental overdose. SAFE Project provides tools and resources and other support to educate the public on the importance of overcoming the stigma relating to overdoses, as well as to encourage the distribution and use of naloxone.
“We are proud partners for this campaign and thrilled with Emergent’s willingness to sponsor this educational initiative,” said Jeff Horwitz, CEO of SAFE Project. “SAFE Project is committed to saving lives from overdoses and, like Emmitt, we appreciate that it takes solid teamwork to make a difference. Collective action is essential to fighting stigma, overcoming overdoses and saving lives. Working together, we can all be Ready to Rescue!”
Learn more about the Ready to Rescue campaign and how to perform the ‘Lay, Spray, Stay’ method in an opioid emergency at www.readytorescue.com.
Emmitt Smith is a paid spokesperson for Emergent.
About NARCAN® Nasal Spray
NARCAN® Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose. NARCAN® Nasal Spray is not a substitute for emergency medical care. Repeat dosing may be necessary. Use as directed.
About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
About SAFE Project
SAFE Project is a national 501(c)(3) nonprofit committed to overcoming the addiction epidemic in the United States. Established in 2017 by Admiral James and Mary Winnefeld after the tragic loss of their 19-year-old son Jonathan due to an opioid overdose, SAFE Project aims to save lives impacted by substance use and mental health challenges through overdose prevention and response, education on stigma, and development of prevention and recovery programs. SAFE Project also provides tailored guidance and training within its four key initiatives: SAFE Campuses, SAFE Communities, SAFE Workplaces, and SAFE Veterans. To learn more, please visit safeproject.us.
Safe Harbor Statement
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are forward-looking statements. We generally identify forward-looking statements by using words like “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “may,” “plan,” “position,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” and similar expressions or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on our current intentions, beliefs and expectations regarding future events based on information that is currently available. We cannot guarantee that any forward-looking statements will be accurate. Readers should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Readers are, therefore, cautioned not to place undue reliance on any forward-looking statements. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, we do not undertake any obligation to update any forward-looking statement to reflect new information, events or circumstances.
There are a number of important factors that could cause the company’s actual results to differ materially from those indicated by any forward-looking statements. Readers should consider this cautionary statement, as well as the risk factors and other disclosures included in our periodic reports filed with the U.S. Securities and Exchange Commission, when evaluating our forward-looking statements.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
References:
- Centers for Disease Control and Prevention. Statement from CDC Chief Medical Officer Dr. Deb Houry on 2023 Overdose Death Data. Available at: https://www.cdc.gov/media/releases/2024/s-overdose-data.html. Accessed July 19, 2024.
- Centers for Disease Control and Prevention. Drug Overdose Data. National Center for Health Statistics, National Vital Statistics System. Available at: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed July 19, 2024.
A video accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/2719b01f-2640-4af6-be4a-f72a55334667
FAQ
What is the 'Lay, Spray, Stay' campaign launched by Emergent BioSolutions (EBS)?
How many drug overdose deaths occurred in 2023 according to Emergent BioSolutions (EBS)?
What is NARCAN® Nasal Spray promoted by Emergent BioSolutions (EBS) in their campaign?
Who partnered with Emergent BioSolutions (EBS) for the 'Lay, Spray, Stay' campaign?
